Comments

Mineralys Therapeutics Insider Trading Activity

MLYSNASDAQ

Logo brought to you by Benzinga Data

Trade with Public

$36.27

-0.63-1.69%

Last update: Dec 15, 2:50 PM

Overview News Earnings Options Analyst Ratings

Insider Trades

Short Interest Stock Report

Mineralys Therapeutics Insider Trading Activity | NASDAQ:MLYS | Benzinga

Track the latest Mineralys Therapeutics insider trading activity. Stay informed on recent buys, sells, and market impact for Mineralys Therapeutics stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are Mineralys Therapeutics Inc Insiders Doing?

At Mineralys Therapeutics Inc, recent insider activity has drawn attention. Over the last 30 days, insiders have reported selling a total of 1.00M shares worth $43.35M, meanwhile, insiders have report no purchases in the last 30 days.

Notable Recent Insider Buys and Sales

On October 15, 2025, Malcom David Rodman, the company's CHIEF MEDICAL OFFICER sold 10.37K shares for $43.01 each.
On October 15, 2025, Adam Levy, the company's CFO AND SECRETARY sold 10.76K shares for $42.01 each.
On October 15, 2025, Jon Congleton, the company's CHIEF EXECUTIVE OFFICER sold 15.1K shares for $42.67 each.

Ownership Statistics for Mineralys Therapeutics Inc

Shares Outstanding

79.140M

Insider Shares Owned

745.938K

Insider Percentage Owned

0.96%

Institutional Shares Held

24.619M

Institutional Percentage Held

31.1%


Nov 21, 2025	Taylor Brian Slingsby Catalys Pacific Fund LP	DIRECTOR	-1.00M	$43.35	-$43.35M	SELL	-11.23%	7.90M	Nov 20	View
Nov 13, 2025	Adam Levy	CFO AND SECRETARY	-13.87K	$29.49	-$3.87M	SELL	-41.70%	19.40K	Nov 11	View
Nov 13, 2025	Jon Congleton	CHIEF EXECUTIVE OFFICER	-200.00K	$45.44	-$9.09M	SELL	-24.06%	631.30K	Nov 11	View
Nov 13, 2025	Daphne Karydas	DIRECTOR	0.00	$28.09	-$536.80K	SELL-OPTIONS	0.00%	0.00	Nov 13	View
Nov 13, 2025	Alexander Gold	DIRECTOR	0.00	$28.19	-$1.20M	SELL-OPTIONS	0.00%	0.00	Nov 11 - Nov 13	View
Oct 15, 2025	Adam Levy	CFO AND SECRETARY	-10.76K	$42.01	-$451.98K	SELL	-8.43%	116.86K	Oct 13	View
Oct 15, 2025	Jon Congleton	CHIEF EXECUTIVE OFFICER	-15.10K	$42.67	-$644.33K	SELL	-1.78%	831.30K	Oct 13	View
Oct 15, 2025	Malcom David Rodman	CHIEF MEDICAL OFFICER	-10.37K	$43.01	-$445.98K	SELL	-12.72%	71.16K	Oct 15	View
Sep 16, 2025	Malcom David Rodman	CHIEF MEDICAL OFFICER	-11.37K	$36.00	-$409.27K	SELL	-12.24%	81.52K	Sep 15	View
Sep 08, 2025	Srinivas Akkaraju	—	588.24K	$25.50	$15.00M	BUY	10.37%	6.26M	Sep 04	View
Sep 08, 2025	RA CAPITAL MANAGEMENT LP RA Capital Healthcare Fund LP RA Capital Nexus Fund III LP Peter Kolchinsky Rajeev Shah	DIRECTOR	1.18M	$25.50	$30.00M	BUY	19.14%	7.32M	Sep 04	View
Aug 14, 2025	Malcom David Rodman	CHIEF MEDICAL OFFICER	-5.02K	$7.01	-$140.13K	SELL	-5.12%	92.89K	Aug 12 - Aug 13	View
Jul 30, 2025	Adam Levy	CFO AND SECRETARY	-73.68K	$14.62	-$1.08M	SELL	-35.66%	132.93K	Jul 28 - Jul 30	View
Jul 15, 2025	Jon Congleton	CHIEF EXECUTIVE OFFICER	-15.88K	$14.51	-$230.43K	SELL	-1.84%	846.40K	Jul 11	View
Jul 15, 2025	Adam Levy	CFO AND SECRETARY	-10.76K	$14.45	-$155.45K	SELL	-4.95%	206.61K	Jul 11	View
Jul 15, 2025	Malcom David Rodman	CHIEF MEDICAL OFFICER	-5.02K	$7.84	-$159.02K	SELL	-4.87%	97.91K	Jul 14	View
Jun 16, 2025	Malcom David Rodman	CHIEF MEDICAL OFFICER	-5.02K	$7.84	-$159.08K	SELL	-4.70%	101.65K	Jun 12 - Jun 13	View
May 15, 2025	Malcom David Rodman	CHIEF MEDICAL OFFICER	-11.37K	$15.29	-$173.77K	SELL	-9.63%	106.67K	May 14	View
Apr 25, 2025	Taylor Brian Slingsby Catalys Pacific Fund LP	DIRECTOR	259.26K	$13.50	$3.50M	BUY	3.00%	8.90M	Mar 13	View
Apr 15, 2025	Malcom David Rodman	CHIEF MEDICAL OFFICER	-5.02K	$7.81	-$158.33K	SELL	-4.30%	111.69K	Apr 14	View
Apr 15, 2025	Adam Levy	CFO AND SECRETARY	-10.76K	$12.06	-$129.68K	SELL	-4.76%	215.34K	Apr 11	View
Apr 15, 2025	Jon Congleton	CHIEF EXECUTIVE OFFICER	-15.32K	$12.19	-$186.80K	SELL	-1.75%	862.29K	Apr 11	View
Apr 03, 2025	Malcom David Rodman	CHIEF MEDICAL OFFICER	-54.16K	$8.42	-$877.27K	SELL	-31.70%	116.70K	Apr 01	View
Mar 17, 2025	Samsara BioCapital GP LLC Samsara BioCapital LP	10% OWNER	600.00K	$13.50	$8.10M	BUY	11.82%	5.67M	Mar 13	View
Mar 17, 2025	Srinivas Akkaraju	—	600.00K	$13.50	$8.10M	BUY	11.82%	5.67M	Mar 13	View
Mar 17, 2025	RA CAPITAL MANAGEMENT LP RA Capital Healthcare Fund LP RA Capital Nexus Fund III LP Peter Kolchinsky Rajeev Shah	DIRECTOR	1.30M	$13.50	$17.50M	BUY	26.72%	6.15M	Mar 13	View
Jan 15, 2025	Adam Levy	CFO AND SECRETARY	-10.76K	$9.10	-$97.86K	SELL	-4.54%	226.10K	Jan 13	View
Jan 15, 2025	Jon Congleton	CHIEF EXECUTIVE OFFICER	-18.33K	$9.06	-$166.08K	SELL	-2.05%	877.61K	Jan 13	View
Nov 12, 2024	Malcom David Rodman	CHIEF MEDICAL OFFICER	5.02K	$7.91	-$67.26K	SELL-OPTIONS	3.69%	140.99K	Nov 11	View
Nov 08, 2024	Malcom David Rodman	CHIEF MEDICAL OFFICER	0.00	$8.06	-$355.55K	SELL-OPTIONS	0.00%	135.97K	Nov 06	View
Oct 15, 2024	Adam Levy	CFO AND SECRETARY	-10.76K	$13.57	-$146.00K	SELL	-4.34%	236.85K	Oct 11	View
Oct 15, 2024	Jon Congleton	CHIEF EXECUTIVE OFFICER	-15.27K	$13.52	-$206.43K	SELL	-1.68%	895.94K	Oct 11	View
Jul 26, 2024	Taylor Brian Slingsby Catalys Pacific Fund LP	DIRECTOR	-550.00K	$13.05	-$7.18M	SELL	-5.98%	8.64M	Jul 24	View
Jul 18, 2024	Malcom David Rodman	CHIEF MEDICAL OFFICER	0.00	$8.04	-$7.31K	SELL-OPTIONS	0.00%	102.87K	Jul 16	View
Jul 12, 2024	Adam Levy	CFO AND SECRETARY	-10.76K	$13.14	-$141.39K	SELL	-4.16%	247.61K	Jul 11	View
Jul 12, 2024	Jon Congleton	CHIEF EXECUTIVE OFFICER	-15.75K	$13.34	-$210.08K	SELL	-1.70%	911.21K	Jul 11	View
Jun 20, 2024	Jon Congleton	CHIEF EXECUTIVE OFFICER	-49.31K	$12.01	-$592.02K	SELL	-5.05%	926.96K	Jun 17 - Jun 20	View
Jun 14, 2024	Jon Congleton	CHIEF EXECUTIVE OFFICER	-72.80K	$12.70	-$924.20K	SELL	-6.94%	976.27K	Jun 12 - Jun 14	View
Jun 13, 2024	Adam Levy	CFO AND SECRETARY	-96.81K	$12.94	-$1.25M	SELL	-27.48%	255.46K	Jun 11	View
May 10, 2024	Malcom David Rodman	CHIEF MEDICAL OFFICER	0.00	$8.04	-$1.39K	SELL-OPTIONS	0.00%	67.00K	May 09	View
Feb 14, 2024	Samsara BioCapital GP LLC Samsara BioCapital LP	10% OWNER	555.55K	$13.50	$7.50M	BUY	12.29%	5.07M	Feb 12	View
Nov 27, 2023	Jon Congleton	CHIEF EXECUTIVE OFFICER	4.25K	$5.97	$25.36K	BUY	0.41%	1.05M	Nov 22	View
Sep 08, 2023	Jon Congleton	CHIEF EXECUTIVE OFFICER	2.25K	$12.08	$27.18K	BUY	0.22%	1.04M	Sep 06	View
Aug 21, 2023	Jon Congleton	CHIEF EXECUTIVE OFFICER	2.25K	$12.10	$27.23K	BUY	0.22%	1.04M	Aug 17	View
Aug 11, 2023	Malcom David Rodman	CHIEF MEDICAL OFFICER	0.00	$6.82	-$2.83M	SELL-OPTIONS	0.00%	0.00	Aug 10 - Aug 11	View
Aug 11, 2023	Jon Congleton	CHIEF EXECUTIVE OFFICER	2.00K	$12.89	$25.78K	BUY	0.19%	1.04M	Aug 11	View
Feb 16, 2023	HBM Healthcare Investments Cayman Ltd	10% OWNER	3.22M	$16.00	$5.00M	BUY	∞	3.22M	Feb 14	View
Feb 16, 2023	RA CAPITAL MANAGEMENT LP RA Capital Healthcare Fund LP RA Capital Nexus Fund III LP Peter Kolchinsky Rajeev Shah	DIRECTOR	3.18M	$16.00	$20.00M	BUY	∞	1.31M	Feb 14	View
Feb 16, 2023	Adam Levy	CFO, CHIEF BUS. OFF. AND SECY.	6.25K	$16.00	$100.00K	BUY	1.81%	350.81K	Feb 14	View
Feb 16, 2023	SRINIVAS AKKARAJU Samsara BioCapital LP	DIRECTOR	4.52M	$16.00	$15.00M	BUY	∞	4.52M	Feb 14	View
Feb 16, 2023	Taylor Brian Slingsby Catalys Pacific Fund LP	DIRECTOR	4.56M	$16.00	$4.00M	BUY	98.57%	9.19M	Feb 14	View

FAQ

Is insider trading legal?

Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.

What are some examples of market manipulation?

Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.